WHO Grade 4 Glioma — Trials

WHO Grade 4 Glioma — Trials · CancerIndex

Clinical trials

Registered studies

1,854 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 535
Recruiting: 286
Ph III recruiting: 15
Growth YoY: +41.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (302)

clinicaltrialsPublishedShowing 101–105 of 105 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00948389	Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)	terminated	Phase 1 / Phase 2	28	Bristol-Myers SquibbINDUSTRY	4	Aug 31, 2012	clinicaltrials
NCT00272870	Treatment of Newly Diagnosed Brain Tumors With Chemotherapy and Radiation Using Cells Modified for Chemoprotection and an Experimental Drug to Decrease the Tumor Cell Resistance to Chemotherapy	terminated	Phase 1	1	Children's Hospital Medical Center, CincinnatiOTHER	1	Aug 29, 2012